Refractory status epilepticus in a pediatric patient: Exploring the association with thyroid dysfunction

被引:0
|
作者
Hmeedan, Alaa [1 ]
Rabee, Hadi Adnan [2 ]
Doudein, Mahmoud [3 ]
Shubietah, Abdalhakim R. M. [4 ,5 ]
机构
[1] An Najah Natl Univ, Internal Med Dept, Nablus, Palestine
[2] Al Watani Hosp, Internal Med Specialist, Nablus, Palestine
[3] Specialized Arab Hosp, Internal Med Dept, Nablus, Palestine
[4] Jaffa Specialized Surg Hosp, Med Surg Dept, Ramallah, Palestine
[5] An Najah Natl Univ, Fac Med & Hlth Sci, POB 7, Nablus 00970, Palestine
来源
OXFORD MEDICAL CASE REPORTS | 2024年 / 2024卷 / 04期
关键词
HASHIMOTO ENCEPHALOPATHY;
D O I
10.1093/omcr/omae031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hashimoto's thyroiditis is an autoimmune thyroid disease characterized by lymphocytic infiltration and thyroid-specific autoantibodies. Hashimoto's encephalopathy, a rare entity associated with these antibodies, presents as a relapsing encephalopathy with neuropsychiatric manifestations and seizures. A 15-year-old girl, initially healthy, experienced a tonic-clonic seizure. Despite unremarkable initial assessments, she returned with generalized convulsive status epilepticus. Hashimoto's thyroiditis was suggested by elevated thyroid-stimulating hormone levels, low thyroxine levels, and high anti-thyroid antibodies, and was confirmed by ultrasound. Steroids were not used initially due to seizure cessation with anesthesia. Post-treatment with levothyroxine and antiepileptics, she was seizure-free at follow-up and eventually maintained solely on levothyroxine. Hashimoto's encephalopathy, characterized by diverse symptoms, often necessitates corticosteroids, immunoglobulins, and plasmapheresis, as traditional anti-seizure medications fail. Further research into its etiology and pathophysiology is essential. Consider Hashimoto's encephalopathy in unexplained seizures, especially with ineffective standard treatments. Pediatric diagnostic criteria need to be revisited.
引用
收藏
页码:149 / 152
页数:4
相关论文
共 50 条
  • [31] EFFICACY OF LEVETIRACETAM IN TWO PEDIATRIC PATIENTS WITH REFRACTORY STATUS EPILEPTICUS
    Mateo, G.
    Buenache, R.
    Morillo, P.
    Pedrera, A.
    Quintana, P.
    Lorenzo, G.
    EPILEPSIA, 2010, 51 : 72 - 72
  • [32] Chikungunya Hemicerebellitis Associated with Refractory Status Epilepticus in Pediatric Age
    Ramirez-Zamora, Mauricio
    Veliz-Martinez, Victor
    Barahona, Guillermo E.
    Mena, Ivan D.
    Ortez, Carlos I.
    Nolasco-Tovar, Gregorio A.
    REVISTA DE NEUROLOGIA, 2020, 71 (03) : 123 - 124
  • [33] Treatment options in pediatric super-refractory status epilepticus
    Arayakarnkul, Palita
    Chomtho, Krisnachai
    BRAIN & DEVELOPMENT, 2019, 41 (04): : 359 - 366
  • [34] Pediatric Super-Refractory Status Epilepticus Treated with Allopregnanolone
    Broomall, Eileen
    Natale, JoAnne E.
    Grimason, Michele
    Goldstein, Joshua
    Smith, Craig M.
    Chang, Celia
    Kanes, Stephen
    Rogawski, Michael A.
    Wainwright, Mark S.
    ANNALS OF NEUROLOGY, 2014, 76 (06) : 911 - 915
  • [35] Refractory status epilepticus
    Singh, Sanjay P.
    Agarwal, Shubhi
    Faulkner, M.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2014, 17 : S32 - S36
  • [36] Refractory status epilepticus
    Bleck, TP
    CURRENT OPINION IN CRITICAL CARE, 2005, 11 (02) : 117 - 120
  • [37] Refractory status epilepticus
    Patle, V.
    Lowe, A.
    ANAESTHESIA, 2016, 71 : 56 - 56
  • [38] Refractory status epilepticus
    Fernandez, Andres
    Claassen, Jan
    CURRENT OPINION IN CRITICAL CARE, 2012, 18 (02) : 127 - 131
  • [39] Refractory status epilepticus
    Singhal, Ankit
    Tripathi, Manjari
    NEUROLOGY ASIA, 2013, 18 : 67 - 71
  • [40] Refractory status epilepticus
    Murthy, J. M. K.
    NEUROLOGY INDIA, 2006, 54 (04) : 354 - 358